vs

Side-by-side financial comparison of Avery Dennison (AVY) and Invesco (IVZ). Click either name above to swap in a different company.

Avery Dennison is the larger business by last-quarter revenue ($2.3B vs $1.7B, roughly 1.4× Invesco). Avery Dennison runs the higher net margin — 7.3% vs -58.9%, a 66.2% gap on every dollar of revenue. On growth, Avery Dennison posted the faster year-over-year revenue change (7.0% vs 6.2%). Invesco produced more free cash flow last quarter ($432.2M vs $104.4M). Over the past eight quarters, Invesco's revenue compounded faster (7.1% CAGR vs 1.4%).

Avery Dennison Corporation is an American multinational manufacturer and distributor of pressure-sensitive adhesive materials, apparel branding labels and tags, RFID inlays, and specialty medical products. The company is a member of the Fortune 500 and is headquartered in Mentor, Ohio.

Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.

AVY vs IVZ — Head-to-Head

Bigger by revenue
AVY
AVY
1.4× larger
AVY
$2.3B
$1.7B
IVZ
Growing faster (revenue YoY)
AVY
AVY
+0.8% gap
AVY
7.0%
6.2%
IVZ
Higher net margin
AVY
AVY
66.2% more per $
AVY
7.3%
-58.9%
IVZ
More free cash flow
IVZ
IVZ
$327.8M more FCF
IVZ
$432.2M
$104.4M
AVY
Faster 2-yr revenue CAGR
IVZ
IVZ
Annualised
IVZ
7.1%
1.4%
AVY

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AVY
AVY
IVZ
IVZ
Revenue
$2.3B
$1.7B
Net Profit
$168.1M
$-995.9M
Gross Margin
28.9%
Operating Margin
10.7%
-86.2%
Net Margin
7.3%
-58.9%
Revenue YoY
7.0%
6.2%
Net Profit YoY
1.1%
-575.8%
EPS (diluted)
$-2.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AVY
AVY
IVZ
IVZ
Q1 26
$2.3B
Q4 25
$2.3B
$1.7B
Q3 25
$2.2B
$1.6B
Q2 25
$2.2B
$1.5B
Q1 25
$2.1B
$1.5B
Q4 24
$2.2B
$1.6B
Q3 24
$2.2B
$1.5B
Q2 24
$2.2B
$1.5B
Net Profit
AVY
AVY
IVZ
IVZ
Q1 26
$168.1M
Q4 25
$166.4M
$-995.9M
Q3 25
$166.3M
$356.4M
Q2 25
$189.0M
$197.4M
Q1 25
$166.3M
$171.1M
Q4 24
$174.0M
$209.3M
Q3 24
$181.7M
$55.0M
Q2 24
$176.8M
$132.2M
Gross Margin
AVY
AVY
IVZ
IVZ
Q1 26
28.9%
Q4 25
28.7%
Q3 25
28.7%
Q2 25
28.8%
Q1 25
28.9%
Q4 24
27.9%
Q3 24
28.7%
Q2 24
29.6%
Operating Margin
AVY
AVY
IVZ
IVZ
Q1 26
10.7%
Q4 25
9.1%
-86.2%
Q3 25
10.6%
16.5%
Q2 25
11.5%
14.1%
Q1 25
10.6%
18.1%
Q4 24
11.0%
19.6%
Q3 24
11.0%
6.6%
Q2 24
10.7%
13.9%
Net Margin
AVY
AVY
IVZ
IVZ
Q1 26
7.3%
Q4 25
7.3%
-58.9%
Q3 25
7.5%
21.7%
Q2 25
8.5%
13.0%
Q1 25
7.7%
11.2%
Q4 24
8.0%
13.1%
Q3 24
8.3%
3.6%
Q2 24
7.9%
8.9%
EPS (diluted)
AVY
AVY
IVZ
IVZ
Q1 26
Q4 25
$2.16
$-2.61
Q3 25
$2.13
$0.66
Q2 25
$2.41
$-0.03
Q1 25
$2.09
$0.38
Q4 24
$2.17
$0.46
Q3 24
$2.25
$0.12
Q2 24
$2.18
$0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AVY
AVY
IVZ
IVZ
Cash + ST InvestmentsLiquidity on hand
$255.1M
$1.0B
Total DebtLower is stronger
$3.2B
$1.8B
Stockholders' EquityBook value
$2.3B
$12.2B
Total Assets
$9.0B
$27.1B
Debt / EquityLower = less leverage
1.38×
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AVY
AVY
IVZ
IVZ
Q1 26
$255.1M
Q4 25
$202.8M
$1.0B
Q3 25
$536.3M
$973.1M
Q2 25
$215.9M
$922.7M
Q1 25
$195.9M
$821.7M
Q4 24
$329.1M
$986.5M
Q3 24
$212.7M
$1.0B
Q2 24
$208.8M
$878.5M
Total Debt
AVY
AVY
IVZ
IVZ
Q1 26
$3.2B
Q4 25
$3.2B
$1.8B
Q3 25
$3.2B
$1.6B
Q2 25
$2.6B
$1.9B
Q1 25
$2.6B
$964.8M
Q4 24
$2.6B
$890.6M
Q3 24
$2.0B
$890.3M
Q2 24
$2.0B
$890.1M
Stockholders' Equity
AVY
AVY
IVZ
IVZ
Q1 26
$2.3B
Q4 25
$2.2B
$12.2B
Q3 25
$2.2B
$14.0B
Q2 25
$2.2B
$13.9B
Q1 25
$2.2B
$14.7B
Q4 24
$2.3B
$14.6B
Q3 24
$2.4B
$14.8B
Q2 24
$2.3B
$14.6B
Total Assets
AVY
AVY
IVZ
IVZ
Q1 26
$9.0B
Q4 25
$8.8B
$27.1B
Q3 25
$8.9B
$28.4B
Q2 25
$8.6B
$28.5B
Q1 25
$8.4B
$28.1B
Q4 24
$8.4B
$27.0B
Q3 24
$8.5B
$27.5B
Q2 24
$8.3B
$27.2B
Debt / Equity
AVY
AVY
IVZ
IVZ
Q1 26
1.38×
Q4 25
1.43×
0.15×
Q3 25
1.45×
0.12×
Q2 25
1.19×
0.14×
Q1 25
1.19×
0.07×
Q4 24
1.11×
0.06×
Q3 24
0.85×
0.06×
Q2 24
0.89×
0.06×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AVY
AVY
IVZ
IVZ
Operating Cash FlowLast quarter
$455.8M
Free Cash FlowOCF − Capex
$104.4M
$432.2M
FCF MarginFCF / Revenue
4.5%
25.5%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$869.1M
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AVY
AVY
IVZ
IVZ
Q1 26
Q4 25
$376.8M
$455.8M
Q3 25
$312.1M
$606.2M
Q2 25
$208.8M
$547.9M
Q1 25
$-16.3M
$-84.6M
Q4 24
$351.2M
$316.9M
Q3 24
$270.1M
$438.4M
Q2 24
$197.7M
$489.1M
Free Cash Flow
AVY
AVY
IVZ
IVZ
Q1 26
$104.4M
Q4 25
$309.7M
$432.2M
Q3 25
$276.2M
$586.4M
Q2 25
$178.8M
$530.4M
Q1 25
$-52.3M
$-108.0M
Q4 24
$281.7M
$309.9M
Q3 24
$227.1M
$410.0M
Q2 24
$150.2M
$462.4M
FCF Margin
AVY
AVY
IVZ
IVZ
Q1 26
4.5%
Q4 25
13.6%
25.5%
Q3 25
12.5%
35.7%
Q2 25
8.1%
35.0%
Q1 25
-2.4%
-7.1%
Q4 24
12.9%
19.5%
Q3 24
10.4%
27.1%
Q2 24
6.7%
31.2%
Capex Intensity
AVY
AVY
IVZ
IVZ
Q1 26
Q4 25
3.0%
1.4%
Q3 25
1.6%
1.2%
Q2 25
1.4%
1.2%
Q1 25
1.7%
1.5%
Q4 24
3.2%
0.4%
Q3 24
2.0%
1.9%
Q2 24
2.1%
1.8%
Cash Conversion
AVY
AVY
IVZ
IVZ
Q1 26
Q4 25
2.26×
Q3 25
1.88×
1.70×
Q2 25
1.10×
2.78×
Q1 25
-0.10×
-0.49×
Q4 24
2.02×
1.51×
Q3 24
1.49×
7.97×
Q2 24
1.12×
3.70×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AVY
AVY

Materials Group$1.6B72%
Solutions Group$649.2M28%

IVZ
IVZ

Investment Advice$1.2B73%
Distribution And Shareholder Service$382.7M23%
Financial Service Other$51.0M3%
Investment Performance$28.9M2%

Related Comparisons